CXCL10 and myeloid sarcoma: To discover a biological marker for the early diagnosis of MS or in an attempt to clinically stratify the disease, researchers have already demonstrated that concentrations of IP-10—combined with the combination with IL-7—seem to serve to rule out the clinical form of PP [22].